Is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 29.9% / 30% | 2.5% / 30% | 8.3% / 30% | 0.12% / 5% | ✓ HALAL |
| DJIM | 29.9% / 33% | 2.5% / 33% | 8.3% / 33% | 0.12% / 5% | ✓ HALAL |
| MSCI | 36.0% / 33% | 3.0% / 33% | 9.9% / 33% | 0.12% / 5% | ✗ NOT HALAL |
| S&P | 29.9% / 33% | 2.5% / 33% | 8.3% / 33% | 0.12% / 5% | ✓ HALAL |
| FTSE | 36.0% / 33% | 3.0% / 33% | 9.9% / 50% | 0.12% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 35.0% | |
| Operating Margin | 4.5% | |
| Net Margin | -3.6% | |
| Return on Equity (ROE) | -4.2% | |
| Return on Assets (ROA) | 4.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $738M |
| Free Cash Flow | $518M |
| Total Debt | $2.6B |
| Debt-to-Equity | 81.9 |
| Current Ratio | 1.3 |
| Total Assets | $7.1B |
Price & Trading
| Last Close | $165.13 |
| 50-Day MA | $180.87 |
| 200-Day MA | $173.46 |
| Avg Volume | 937K |
| Beta | 1.7 |
|
52-Week Range
$91.86
| |
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Purification Calculator
As a halal stock with 0.12% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s debt ratio?
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s debt ratio is 29.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 36.0%.
Does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. require dividend purification?
Yes, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. has an impermissible income ratio of 0.12%, which means 0.12% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s key financial metrics?
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. has a market capitalization of $7.8B, and revenue of $4.0B. The company maintains a gross margin of 35.0% and a net margin of -3.6%. Return on equity stands at -4.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.